Tuesday, October 25, 2016
Today's Research Daily features new research reports on 16 major stocks, including AT&T (NYSE:T), General Mills (NYSE:GIS) and Pfizer (NYSE:PFE).
AT&T is in the headlines because of the Time Warner (TWX) deal, which will likely get plenty of regulatory scrutiny. The stock had lost ground prior to the deal announcement as the market's earlier affinity big dividend-paying telecom stocks had cooled off to some extent. That said, it is still up more than 7% year-to-date, doing better than both Verizon as well as the broader S&P 500 index. AT&T's Q3 results were mixed, though the strategic rationale for the Time Warner deal is compelling. (You can read the full research report on AT&T here>>)
General Mills shares have not been doing too well lately, likely reflecting weakness in the company's U.S. Retail segment as a result of lower demand amid changing consumer food preferences. But the analyst likes its robust restructuring savings, which are making up for the slower revenue growth. Though consumer-focused innovation and marketing drive as well as greater distribution of natural and organic portfolio helped improve the top line on many businesses in segments like cereals and snacks in fiscal 2016, a material improvement may take time. (You can read the full research report on General Mills here>>)
Pfizer shares have lagged the market this year, in line with the broader the pharmaceutical space, on concerns about the group's pricing power in the current political environment. These issues notwithstanding, the analyst likes Pfizer’s strategy of strengthening its product portfolio and pipeline through acquisitions and licensing deals. The 2015 Hospira acquisition has significantly expanded Pfizer's sterile injectable and biosimilar capabilities. However, headwinds remain in the form of genericization and the expiration of a few co-promotion agreements which will continue to hamper top-line growth. Estimate movement has been mixed lately ahead of the company’s Q3 earnings release. (You can read the full research report on Pfizer here>>)
Other noteworthy reports we are featuring today include T-Mobile (TMUS), United Continental (UAL), and AvalonBay Communities (NYSE:AVB).
You can find all of today's stock research reports here>>
Confidential: Best Trades from Zacks Research
Would you like to see a hand-picked "all-star" selection of investment ideas from the man who heads up Zacks' trading and investing services? Steve Reitmeister knows when key trades are about to be triggered and which of our experts has the hottest hand. Click for his prized selections right now >>
Sheraz Mian
Director of Research
Note: If you want an email notification each time Sheraz publishes a new article, please click here >>
Today's Must Read
Featured Reports
T-Mobile US (TMUS) Continues its Customer Additions Spree
The Zacks analyst believes that T-Mobile's 14th straight quarter of customer additions helped to beat street estimates in Q3 2016
United Continental (UAL) Q3 Earnings and Sales Top; Fall Y/Y
Though the covering analyst appreciates the company's better-than-expected earnings and revenues in the third quarter, the year-over-year fall in both metrics is a drag. Low air fares hurt the results.
Moody's (MCO) Q3 Earnings Strong But DOJ Issue a Concern
The Zacks analyst thinks Moody's strong quarterly results were impressive but the fresh trouble with DOJ relating to RMBS and CLO ratings assigned prior to 2008 financial crisis is unnerving.
E*TRADE (ETFC) Q3 Earnings Up, Focused on Trading Business
The covering analyst remains optimistic on E*TRADE's strong Q3 results and renewed focus on strengthening its brokerage business with the target of achieving 2-3% incremental growth.
Weak 4Q Ahead for Sonoco (SON)
The Zacks analyst believes that while a stronger dollar, fewer business days will hurt fourth-quarter results, Sonoco's overall performance in 2016 will improve y-o-y.
Silicon Motion (SIMO) Increases Dividend
The Zacks analyst notes that the recent dividend hike reflects Silicon Motion's growing business stability, balance sheet strength and improving liquidity.
Texas Capital's (TCBI) Q3 Earnings Reflect Revenue Strength
The Zacks analyst remains optimistic as Texas Capital kept its revenue growth momentum alive in Q3 driven by growth in both net interest income and fee income.
New Upgrades
SunTrust's (STI) Q3 Results Reflect Enhanced Focus on Revenues
The Zacks analyst thinks SunTrust's Q3 results indicate impressive efforts being undertaken to enhance revenue growth. Further, deal to acquire Pillar Financial will lead to revenue synergies in 2017.
Citrix (CTXS) Upgraded on Q3 Earnings and Revenues Beat
As per the covering analyst, Citrix looks poised for growth after earnings and revenues beat in the third quarter. The company's raised guidance for 2016 also impresses.
LyondellBasell (LYB) Well Placed on Capacity Expansion
The Zacks analyst believes LyondellBasell is progressing well with its ethylene expansion projects leveraging the U.S. NGLs advantage, which should boost capacity and add to its earnings.
New Downgrades
AvalonBay (AVB) Q3 FFO Lags Estimates; Supply to Hurt Growth
The Zacks analyst thinks AvalonBay's lower-than-expected Q3 result is discouraging. Higher supply is anticipated to lead to moderation of rental revenue growth. Also, concessions are likely to go up.
V.F. Corp. (VFC) Cuts Outlook on Q3 Earnings & Sales Miss
The covering analyst thinks currency woes and other global economic challenges hurt V.F. Corp.'s third-quarter 2016 results, which lagged estimates. Consequently, the company lowered its 2016 outlook.
Textron (NYSE:TXT) Q3 Earnings Meets Estimates, Down Y/Y
The Zacks analyst believes that disappointing results at Textron's Bell segment has affected the company's overall performance during the quarter.
UNITED CONT HLD (UAL): Free Stock Analysis Report
T-MOBILE US INC (TMUS): Free Stock Analysis Report
AT&T INC (T): Free Stock Analysis Report
PFIZER INC (PFE): Free Stock Analysis Report
GENL MILLS (GIS): Free Stock Analysis Report
AVALONBAY CMMTY (AVB): Free Stock Analysis Report
Original post
Zacks Investment Research